ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TMG The Mission Group Plc

23.50
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Group Plc LSE:TMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 23.50 23.00 24.00 23.50 23.50 23.50 231,501 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Advertising Agencies 195.89M -12.03M -0.1321 -1.78 21.39M
The Mission Group Plc is listed in the Advertising Agencies sector of the London Stock Exchange with ticker TMG. The last closing price for The Mission was 23.50p. Over the last year, The Mission shares have traded in a share price range of 10.50p to 50.50p.

The Mission currently has 91,015,897 shares in issue. The market capitalisation of The Mission is £21.39 million. The Mission has a price to earnings ratio (PE ratio) of -1.78.

The Mission Share Discussion Threads

Showing 5776 to 5798 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
22/1/2020
14:25
Yeah, exactly, this is one of the few stocks that didn't get re-rated after the election. Got some catching up to do.
f15jcm
22/1/2020
14:15
f15lcm,

Not kidding WPP has about £7bn in debt

forward Divi cover here is now over 4x and a fPER of just 8

I honestly think profit taking in Autumn 2019 has been the drag, but new investors are buyin in here at a disount to the wider index of almost 50% off (consider the all share is above 15x PER now).

thorpematt
22/1/2020
13:19
Certainly looks cheap against WPP which is on much greater leverage. Sector seems a bit out of vogue due to global growth concerns. Marketing being very much discretional spend.
f15jcm
22/1/2020
09:43
Solid if unspectacular suits me in these tough economic climbs! Quality run outfit, going for bid as end game here...
johndoe23
22/1/2020
09:22
also 'we expect the Group to be debt free/cash positive at the end of 2020'.
mfhmfh
22/1/2020
09:16
Yes, through the stormy seas, which is testimony to the quality of the company and underpins that it should have a higher rating:10 years of steady growth is an elite, that should command a premium. And by comparison just look at Saatchi smashing onto the rocks. Also, presumably tech subsiduary Pathfindr is sucking up investment,though at some point it should make serious returns. Still unloved and undervalued, but I don't think that will last forever.
bbluesky
22/1/2020
09:16
Interim results on 25.09.19 stated this:

'A strong second-half bias again predicted'

Outlook:

'As in previous years, we expect the majority of our profit to be generated in the second half of the year. Despite the heightened level of Brexit uncertainty, we remain on track to deliver against expectations.'

The company accelerated in the 2nd half and met expectations.

Looking for share price to reach new highs/triple figures.

All IMHO.

mfhmfh
22/1/2020
08:45
At the recent level of 70p the market was clearly expecting a warning so I'm happy and bought back at the open for ~84p, having sold out at 84.17p on 11th November.

I agree with 'solid if unspectacular' but valuations in the market as a whole are starting to look very stretched and this still offers great value, so in relative terms and with debt soon to be history, a strong buy IMO. I'm sure Simon Thompson will agree.

f15jcm
22/1/2020
08:14
Solid if unspectacular. Revenue and profit growth, on course to be debt free this year...
johndoe23
22/1/2020
07:12
That’s decent enough. No figures though, just inline with expectations - last few years they have given % figures.
dr biotech
10/1/2020
09:26
Expecting a positive update
johndoe23
10/1/2020
08:40
Still ludicrous value. Trading update last year was 22 Jan.
bbluesky
09/1/2020
16:33
Thanks JeffH

From 2018 annual report:

"Focus on technology through our fuse initiative which is seeing our Pathfindr asset management system grow dramatically through global contracts with Rolls-
Royce, MTU Friedrichshafen GmbH and GKN Aerospace. Pathfindr generated sales of £0.5m in 2018 (2017: minimal) and we estimate sales of £2m in 2019,
underpinned by a strong order book."

And interim 30 June 2019:

"Our fuse technology division is seeing some exciting new initiatives develop, a couple of which should be ready for launch in 2020, whilst our Pathfindr Asset Management System continues to expand its Client base with some excellent new contracts. It is gratifying to note that wherever Pathfindr is trialed, it quite quickly becomes the system of choice; so much so that we will be
accelerating our investment and reaching out into new markets."

TMG - a creative company in more senses than just the industry "trope".

cliffpeat
07/1/2020
20:39
They own pathfindr ali!
jeff h
07/1/2020
19:32
i know from memeory there is a relationshp between TMG and pathfinder but don't remember what it is - can you please clarify jeff!
ali47fish
07/1/2020
17:50
Excellent spot Jeff H. Informative article. Easy to see the upside for such a product and no surprise it is, reading between the lines, gathering serious momentum. Big savings and efficiencies to be had and the bigger the player, such as Rolls Royce, the more attractive it be.
bbluesky
07/1/2020
12:59
Article on pathfindr:-
jeff h
16/12/2019
15:34
Its thinly traded. Doubt there is any news today, just joining the general Boris party - nice to see. I made about 6 months take home in the last two days (not all here obviously).
dr biotech
16/12/2019
13:06
can't stand this company for its unpredictible movements and there are rarely news in advance to inform investing?
ali47fish
04/12/2019
08:47
Saatchi are down heavily this morning. Accounting issues and poor trading outlook - they are down about 80% over a year...just have to be happy we’re no them.
dr biotech
03/12/2019
17:11
t/s was 22/jan this yr
wynmck
03/12/2019
15:57
This has been a rather disappointing downward trend for a short while. Any positive updates likely in the near future?
dmdmdmdm1
29/11/2019
19:37
Pathfindr sry autocorrect has taken over.
bbluesky
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older

Your Recent History

Delayed Upgrade Clock